Novartis Leqvio ® (inclisiran) FDA Approved Cholesterol-Lowering Medication
Norman Lepor, cardiologist and a clinical investigator in the Phase III clinical program for Leqvio ® (inclisiran), discusses the recent FDA approval...
5240 articles
Norman Lepor, cardiologist and a clinical investigator in the Phase III clinical program for Leqvio ® (inclisiran), discusses the recent FDA approval...
In this segment, Neal speaks with healthcare veteran Nancy Lurker, President and CEO of EyePoint Pharmaceuticals, who discussed how Lurker transformed E...
Kyle Detwiler, CEO of multinational medical cannabis operator Clever Leaves Holdings, discusses how Clever Leaves is supporting the Colombian community ...
Laura Dix, Managing Director in Accenture’s Life Sciences Strategy and Consulting practice in London, UK, discusses new research titled The "New" ...
Craig Eagle, MD, Chief Medical Officer at Guardant Health discusses a new study published in "Nature Medicine" which demonstrated that using the Guardan...
Grant Simic, Executive Population Health Partner for U.S. Learn more on Health Professional Radio.
Jeffrey Dlott, Medical Director, Consumer Health at Quest Diagnostics discusses the company's new virtual preventive care service called the Comprehensi...
Ken Hansraj, MD, a New York based spinal and orthopedic surgeon discusses "LIFT: Meditations To Boost Back Health" a six-track CD inspired by his daily ...
Jim Gilligan, President and Chief Scientific Officer discusses Tryp Therapeutics, a pharmaceutical company focused on developing psilocybin-based compou...
Colin Lake, Vice President of Digital Business Transformation for Neurology at UCB, discusses the company’s approach to digital solutions and how they...